These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28368425)

  • 21. Risk of colorectal cancer for carriers of a germ-line mutation in POLE or POLD1.
    Buchanan DD; Stewart JR; Clendenning M; Rosty C; Mahmood K; Pope BJ; Jenkins MA; Hopper JL; Southey MC; Macrae FA; Winship IM; Win AK
    Genet Med; 2018 Aug; 20(8):890-895. PubMed ID: 29120461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High mutational burden in colorectal carcinomas with monoallelic POLE mutations: absence of allelic loss and gene promoter methylation.
    Hühns M; Nürnberg S; Kandashwamy KK; Maletzki C; Bauer P; Prall F
    Mod Pathol; 2020 Jun; 33(6):1220-1231. PubMed ID: 31857678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concurrent genetic alterations in DNA polymerase proofreading and mismatch repair in human colorectal cancer.
    Yoshida R; Miyashita K; Inoue M; Shimamoto A; Yan Z; Egashira A; Oki E; Kakeji Y; Oda S; Maehara Y
    Eur J Hum Genet; 2011 Mar; 19(3):320-5. PubMed ID: 21157497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High incidence of epithelial cancers in mice deficient for DNA polymerase delta proofreading.
    Goldsby RE; Hays LE; Chen X; Olmsted EA; Slayton WB; Spangrude GJ; Preston BD
    Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15560-5. PubMed ID: 12429860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The POLD1
    Job A; Tatura M; Schäfer C; Lutz V; Schneider H; Lankat-Buttgereit B; Zielinski A; Borgmann K; Bauer C; Gress TM; Buchholz M; Gallmeier E
    Sci Rep; 2020 Nov; 10(1):18924. PubMed ID: 33144657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive analysis of POLE and POLD1 Gene Variations identifies cancer patients potentially benefit from immunotherapy in Chinese population.
    Yao J; Gong Y; Zhao W; Han Z; Guo S; Liu H; Peng X; Xiao W; Li Y; Dang S; Liu G; Li L; Huang T; Chen S; Song L
    Sci Rep; 2019 Oct; 9(1):15767. PubMed ID: 31673068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rare germline variants in POLE and POLD1 encoding the catalytic subunits of DNA polymerases ε and δ in glioma families.
    Weber CAM; Krönke N; Volk V; Auber B; Förster A; Trost D; Geffers R; Esmaeilzadeh M; Lalk M; Nabavi A; Samii A; Krauss JK; Feuerhake F; Hartmann C; Wiese B; Brand F; Weber RG
    Acta Neuropathol Commun; 2023 Nov; 11(1):184. PubMed ID: 37990341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of POLE and POLD1 in familial cancer.
    Mur P; García-Mulero S; Del Valle J; Magraner-Pardo L; Vidal A; Pineda M; Cinnirella G; Martín-Ramos E; Pons T; López-Doriga A; Belhadj S; Feliubadaló L; Munoz-Torres PM; Navarro M; Grau E; Darder E; Llort G; Sanz J; Ramón Y Cajal T; Balmana J; Brunet J; Moreno V; Piulats JM; Matías-Guiu X; Sanz-Pamplona R; Aligué R; Capellá G; Lázaro C; Valle L
    Genet Med; 2020 Dec; 22(12):2089-2100. PubMed ID: 32792570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. POLE and POLD1 screening in 155 patients with multiple polyps and early-onset colorectal cancer.
    Esteban-Jurado C; Giménez-Zaragoza D; Muñoz J; Franch-Expósito S; Álvarez-Barona M; Ocaña T; Cuatrecasas M; Carballal S; López-Cerón M; Marti-Solano M; Díaz-Gay M; van Wezel T; Castells A; Bujanda L; Balmaña J; Gonzalo V; Llort G; Ruiz-Ponte C; Cubiella J; Balaguer F; Aligué R; Castellví-Bel S
    Oncotarget; 2017 Apr; 8(16):26732-26743. PubMed ID: 28423643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutation spectrum of POLE and POLD1 mutations in South East Asian women presenting with grade 3 endometrioid endometrial carcinomas.
    Wong A; Kuick CH; Wong WL; Tham JM; Mansor S; Loh E; Jain S; Vikas NN; Tan SH; Chan SH; Li ST; Chew SH; Hong W; Ngeow J
    Gynecol Oncol; 2016 Apr; 141(1):113-20. PubMed ID: 26748215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A cancer-associated DNA polymerase delta variant modeled in yeast causes a catastrophic increase in genomic instability.
    Daee DL; Mertz TM; Shcherbakova PV
    Proc Natl Acad Sci U S A; 2010 Jan; 107(1):157-62. PubMed ID: 19966286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic diagnosis of high-penetrance susceptibility for colorectal cancer (CRC) is achievable for a high proportion of familial CRC by exome sequencing.
    Chubb D; Broderick P; Frampton M; Kinnersley B; Sherborne A; Penegar S; Lloyd A; Ma YP; Dobbins SE; Houlston RS
    J Clin Oncol; 2015 Feb; 33(5):426-32. PubMed ID: 25559809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Germline and somatic polymerase ε and δ mutations define a new class of hypermutated colorectal and endometrial cancers.
    Briggs S; Tomlinson I
    J Pathol; 2013 Jun; 230(2):148-53. PubMed ID: 23447401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The burden of faulty proofreading in colon cancer.
    Seshagiri S
    Nat Genet; 2013 Feb; 45(2):121-2. PubMed ID: 23358219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional landscapes of POLE and POLD1 mutations in checkpoint blockade-dependent antitumor immunity.
    Ma X; Riaz N; Samstein RM; Lee M; Makarov V; Valero C; Chowell D; Kuo F; Hoen D; Fitzgerald CWR; Jiang H; Alektiar J; Alban TJ; Juric I; Parthasarathy PB; Zhao Y; Sabio EY; Verma R; Srivastava RM; Vuong L; Yang W; Zhang X; Wang J; Chu LK; Wang SL; Kelly DW; Pei X; Chen J; Yaeger R; Zamarin D; Zehir A; Gönen M; Morris LGT; Chan TA
    Nat Genet; 2022 Jul; 54(7):996-1012. PubMed ID: 35817971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exonuclease mutations in DNA polymerase epsilon reveal replication strand specific mutation patterns and human origins of replication.
    Shinbrot E; Henninger EE; Weinhold N; Covington KR; Göksenin AY; Schultz N; Chao H; Doddapaneni H; Muzny DM; Gibbs RA; Sander C; Pursell ZF; Wheeler DA
    Genome Res; 2014 Nov; 24(11):1740-50. PubMed ID: 25228659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Solving the enigma of POLD1 p.V295M as a potential cause of increased cancer risk.
    Mur P; Magraner-Pardo L; García-Mulero S; Díez-Villanueva A; Del Valle J; Ezquerro E; Lázaro C; Capellá G; Moreno V; Sanz-Pamplona R; Pons T; Valle L
    Eur J Hum Genet; 2022 Apr; 30(4):485-489. PubMed ID: 34285382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional Analysis of Cancer-Associated DNA Polymerase ε Variants in
    Barbari SR; Kane DP; Moore EA; Shcherbakova PV
    G3 (Bethesda); 2018 Mar; 8(3):1019-1029. PubMed ID: 29352080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical features of polymerase proof-reading associated polyposis (PPAP) and recommendations for patient management.
    Palles C; Martin L; Domingo E; Chegwidden L; McGuire J; Cuthill V; Heitzer E; ; Kerr R; Kerr D; Kearsey S; Clark SK; Tomlinson I; Latchford A
    Fam Cancer; 2022 Apr; 21(2):197-209. PubMed ID: 33948826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Germline PMS2 and somatic POLE exonuclease mutations cause hypermutability of the leading DNA strand in biallelic mismatch repair deficiency syndrome brain tumours.
    Andrianova MA; Chetan GK; Sibin MK; Mckee T; Merkler D; Narasinga RK; Ribaux P; Blouin JL; Makrythanasis P; Seplyarskiy VB; Antonarakis SE; Nikolaev SI
    J Pathol; 2017 Nov; 243(3):331-341. PubMed ID: 28805995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.